| Novartis India Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 500672 |
NSE Symbol : NOVARTIND |
P/E(TTM) : 20.94 |
|
ISIN Demat : INE234A01025 |
Div & Yield% : 3.03 |
EPS(TTM) : 39.38 |
|
Book Value(₹) : 313.91 |
Market Cap(₹Cr) : 2,035.76 |
Face Value(₹) : 5.00 |
| Particulars | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 85.90 | 90.33 | 87.55 | 83.88 | 93.00 | 87.10 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 85.90 | 90.33 | 87.55 | 83.88 | 93.00 | 87.10 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 8.75 | 9.40 | 10.61 | 10.63 | 10.60 | 10.32 |
| Total Income | 94.65 | 99.73 | 98.16 | 94.51 | 103.60 | 97.42 |
| Total Expenditure | 63.54 | 66.45 | 60.31 | 59.97 | 67.42 | 69.14 |
| PBIDT | 31.11 | 33.28 | 37.85 | 34.54 | 36.18 | 28.28 |
| Interest | 0.98 | 0.11 | 0.10 | 0.12 | 0.36 | 0.14 |
| PBDT | 30.13 | 33.17 | 37.75 | 34.42 | 35.82 | 28.14 |
| Depreciation | 0.48 | 0.52 | 0.53 | 0.53 | 0.53 | 0.58 |
| Tax | 13.94 | 8.48 | 9.60 | 3.84 | 9.77 | 8.22 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -0.38 | -0.05 | 0.00 | 0.75 | 0.07 | -1.07 |
| Reported Profit After Tax | 16.09 | 24.22 | 27.62 | 29.30 | 25.45 | 20.41 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 16.09 | 24.22 | 27.62 | 29.30 | 25.45 | 20.41 |
| EPS (Unit Curr.) | 6.52 | 9.81 | 11.19 | 11.87 | 10.31 | 8.27 |
| EPS (Adj) (Unit Curr.) | 6.52 | 9.81 | 11.19 | 11.87 | 10.31 | 8.27 |
| Calculated EPS (Unit Curr.) | 6.52 | 9.81 | 11.19 | 11.87 | 10.31 | 8.27 |
| Calculated EPS (Adj) (Unit Curr.) | 6.52 | 9.81 | 11.19 | 11.87 | 10.31 | 8.27 |
| Calculated EPS (Ann.) (Unit Curr.) | 26.08 | 39.25 | 44.76 | 47.49 | 41.25 | 33.08 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 26.08 | 39.25 | 44.76 | 47.49 | 41.25 | 33.08 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 12.34 | 12.34 | 12.34 | 12.34 | 12.34 | 12.34 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 36.22 | 36.84 | 43.23 | 41.18 | 38.90 | 32.47 |
| PBDTM(%) | 35.08 | 36.72 | 43.12 | 41.03 | 38.52 | 32.31 |
| PATM(%) | 18.73 | 26.81 | 31.55 | 34.93 | 27.37 | 23.43 |